site stats

Btai stock price target

WebPrice To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for BioXcel Therapeutics (BTAI) WebApr 12, 2024 · The latest price target for BioXcel Therapeutics ( NASDAQ: BTAI) was reported by Jefferies on March 10, 2024. The analyst firm set a price target for $22.00 …

BioXcel Therapeutics (BTAI) Price To Cash Flow - Zacks.com

WebJul 26, 2024 · Recently, the Street’s analysts have tapped three stocks they see as long-term winners – but with low share value right now. According to TipRanks' database, these are Strong Buy stocks, featuring... rob sally face https://pipermina.com

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Director Krishnan …

WebApr 11, 2024 · BTAI has been the topic of several research reports. The Goldman Sachs Group raised their price target on shares of BioXcel Therapeutics from $16.00 to $26.00 and gave the company a “neutral ... WebApr 6, 2024 · The price target raised to $80 per share is four times as large as the last closing price. BXCL501, the treatment identified as Igalmi after its FDA approval, is … WebApr 11, 2024 · Summit Therapeutics - SMMT Stock Forecast, Price & News $1.53 -0.04 (-2.55%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $1.51 $1.61 50-Day Range $1.38 $3.88 52-Week Range $0.66 $5.78 Volume 1.17 million shs Average Volume 2.79 million shs Market Capitalization $1.07 billion P/E Ratio N/A Dividend Yield N/A Price … rob salter-church pwc

BTAI Stock Price BioXcel Therapeutics Inc. Stock Quote …

Category:BioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote

Tags:Btai stock price target

Btai stock price target

BTAI - BioXcel Therapeutics Inc Stock quote - CNNMoney.com

Web1 day ago · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $49.33. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of... WebMar 22, 2024 · Get The Latest BTAI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,001.09(-0.04%) DOW 32,486.38(-0.23%) QQQ 311.07(+0.24%) AAPL 160.03(+0.47%) MSFT 277.05(+1.19%) META 204.05(+0.93%) GOOGL 105.30(+0.36%) AMZN 100.19(-0.42%) …

Btai stock price target

Did you know?

WebStock Price Forecast The 10 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 49.00, with a high estimate of 75.00 and a low … WebBTAI has a higher average analyst price target than 2939.86% of stocks in the small market cap category. In the context of stocks in the small market cap category, BIOXCEL …

WebMar 10, 2024 · BTAI Price Target For more insight on analysts targets of BTAI, see our BTAI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. Average Price Target $92.55 Average Broker Recommendation 1.3 (Strong Buy) BTAI Stock Price Chart Interactive … WebApr 11, 2024 · Lowest-Rated Stocks NYSE:CVNA Carvana - CVNA Price Target & Analyst Ratings $8.93 +0.43 (+5.06%) (As of 04/6/2024 02:22 PM ET) Compare Today's Range $8.16 $9.00 50-Day Range $6.50 $14.45 52-Week Range $3.55 $116.15 Volume 5.13 million shs Average Volume 25.49 million shs Market Capitalization $1.69 billion P/E …

WebThe analyst firm set a price target for 66.00 expecting BTAI to rise to within 12 months (a possible 282.17% upside). 16 analyst firms have reported ratings in the last year. WebBTAI Analyst Ratings Consensus Analyst Firms Making Recommendations Analyst Back to BTAI Overview Analyst price targets provided by TipRanks. About Analyst Research …

WebBTAI Stock 12 Months Forecast. Average Price Target. $46.00. (146.52% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Bioxcel Therapeuticsin the last …

WebBTAI U.S.: Nasdaq BioXcel Therapeutics Inc. Watch list Create BTAI Alert After Hours Last Updated: Apr 3, 2024 4:49 p.m. EDT Delayed quote $ 19.10 0.00 0.00% After Hours … rob salamida co inc bought outWebApr 10, 2024 · A number of equities research analysts have recently weighed in on BTAI shares. HC Wainwright lowered their price target on BioXcel Therapeutics from $79.00 to $66.00 and set a “buy” rating... rob sainsbury scotiabankWebBioxcel Therapeutics (BTAI) Stock Price & Analysis 1,038 Followers BTAI Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $8.80 - $34.13 Previous … rob samborn author